Literature DB >> 4221626

A histochemical and electron microscopic study of skeletal muscle in a case of Pompe's disease (glycogenosis II).

R D Cardiff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4221626

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

1.  Skeletal muscle glycogenosis type II: biochemical and electron microscopic investigations of one case.

Authors:  N Canal; L Frattola; G Pellegrini
Journal:  Z Neurol       Date:  1972

2.  Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle.

Authors:  J J Martin; T de Barsy; F van Hoof; G Palladini
Journal:  Acta Neuropathol       Date:  1973-02-19       Impact factor: 17.088

3.  Type 3 a glycogenosis. A biochemical and ultrastructural study.

Authors:  F M Paluello; C B Bruni; H Spiele
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1967

4.  Further purification and characterization of the acid alpha-glucosidase.

Authors:  F Auricchio; C B Bruni; V Sica
Journal:  Biochem J       Date:  1968-06       Impact factor: 3.857

5.  [Histochemistry of mucopolysaccharide-like substances (basophilic substances) in skeletal muscle in neuromuscular glycogenosis (type II)].

Authors:  R Schnabel
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

6.  The symptomatology, morphology and biochemistry of glycogenosis type II (Pompe) in the adult.

Authors:  G K Schlenska; R Heene; G Spalke; D Seiler
Journal:  J Neurol       Date:  1976-06-14       Impact factor: 4.849

7.  Generalized glycogenosis type II (Pompe's disease).

Authors:  M R Nihill; D S Wilson; K Hugh-Jones
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

8.  Comparative pathology of the canine model of glycogen storage disease type II (Pompe's disease).

Authors:  H C Walvoort; J A Dormans; T S van den Ingh
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.